• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      MSD India launches antibiotic ZIENAM in the market:

      Posted AtNew Kerala

      Merck & Co of USA, known as MSD Pharmaceuticals Limited in India, has introduced ZIENAM, a broad spectrum antibiotic developed and marketed by its US-based parent copany, in the Indian pharmaceutical market.

      ZIENAM is a highly effective drug in the treatment of patients, who have developed resistance to antibiotics and therefore is a true response to the global problem of drug resistance.

      MSD India Pharma which has plans to invest in sales, marketing and research operations over the next five years, said in a statement that ZIENAM is a prescription drug used in the therapy of Hospital bacterial infections and is indicated for prophylaxis as well as treatment.

      Imipenem, the key component of ZIENAM, makes the drug highly effective against pathogens of the gram-positive, gram-negative as well as aerobic and anaerobic spectra.

      Since the bactericidal activity of b-lactam antibiotics is broader than that of other antibiotic strains, ZIENAM is particularly indicated for the treatment of intra-abdominal infections, infections of the respiratory tract, gynecological and genitourinary infections, Septicemia, skin and soft tissue infections, endocarditis and bone and joint infections.

      ''The launch of ZIENAM in India is part of Merck's continued commitment to introducing medicines and vaccines recognized by the medical community globally as key products for changing the course of diseases'', said Mr. Murali Parthasarathy, Marketing Director, MSD India.

      He said that the drug was key especially in the treatment of hospitalized patients, who developed strong resistance to a wide spectrum of anti-microbial agents and whose infections have become life threatening.

      According to medical experts, Antibiotic drug resistance is spreading in the developing world threatening the lives of millions.

      Every hour, they said, about 1 500 people die from an infectious disease - over half of them are children under five.

      The medical fraternity in India is confronted with increased drug resistance when treating patients with infectious diseases caused by pathogens, they added.

      September 18, 2005


      Share this Article!

    Back to top^